Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 28-09-2021

Claim your CME credit at https://reachmd.com/programs/cme/latest-clinical-advances-treatment-braf-v600e-mutated-metastatic-colorectal-cancer/11863/

Dr. Scott Kopetz and Prof. Eric Van Cutsem evaluate both the initial and updated pivotal outcomes from the BEACON trial in second- and third-line BRAF V600E-mutated metastatic colorectal cancer. They extend their discussion of these practice-changing results to include the early-stage findings from the ANCHOR trial in the first-line setting. This podcast also highlights the central role of anti-EGFR therapies in the management of patients with BRAF V600E-mutated metastatic colorectal cancer.

Additional downloadable slides will be available soon.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD